EDAP TMS SA
(NASDAQ : EDAP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.77%507.471.0%$627.63m
DHRDanaher Corp. -1.39%258.500.7%$627.39m
MDTMedtronic Plc -1.74%80.840.6%$535.11m
ABTAbbott Laboratories -1.53%96.790.8%$533.32m
ISRGIntuitive Surgical, Inc. -0.86%187.440.8%$338.31m
SYKStryker Corp. -1.22%202.971.3%$302.85m
BSXBoston Scientific Corp. -1.47%38.761.0%$258.59m
BDXBecton, Dickinson & Co. -1.46%222.831.0%$255.81m
EWEdwards Lifesciences Corp. -1.34%82.710.4%$237.54m
ALGNAlign Technology, Inc. -1.85%207.116.4%$191.01m
DXCMDexCom, Inc. -1.90%80.541.9%$186.37m
AAgilent Technologies, Inc. -0.84%121.711.7%$182.61m
BAXBaxter International, Inc. -2.50%53.921.8%$166.39m
STESTERIS Plc (Ireland) -0.27%166.663.1%$137.19m
SWAVShockwave Medical, Inc. 0.81%278.070.0%$136.12m

Company Profile

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.